fbpx
0f9407626e83ba22b

Scintica & Trust Bio-sonics

Scintica and Trust Bio-sonics announce exclusive partnership for the distribution of its preclinical USphere™ Series Contrast Agents [January 27, 2022] Scintica is excited to announce its exclusive distribution agreement for North America and Europe with Trust Bio-sonics, a pharmaceutical company and developer of the USphere Series of contrast agents for translational research and medicine

By |2022-01-27T10:51:45-05:00January 27th, 2022|Categories: News|Comments Off on Scintica & Trust Bio-sonics

Myr & Scintica

Scintica and Especialidades Médicas Myr, S.L. announce exclusive partnership for the distribution of its Electromedical Instruments for Anatomical Pathology [January 24, 2022] Scintica is excited to announce its exclusive distribution agreement for Canada with Especialidades Médicas Myr, S.L., developer, and manufacturer of electromedical instruments for anatomical pathology. Myr has over 30 years of experience

By |2022-01-27T10:53:59-05:00January 24th, 2022|Categories: News|Comments Off on Myr & Scintica

Scintica and Aspect Imaging Announce New Extended Partnership

[January 5, 2022] Scintica is excited to announce its new and extended distribution agreement for preclinical products with Aspect Imaging, global leader in innovative, high-performance permanent magnet MRI technology. Aspect imaging has been pushing the boundaries of permanent magnet design to deliver easy-to-use MR imaging solutions for both clinical and preclinical market segments. The

By |2022-01-05T11:46:15-05:00January 5th, 2022|Categories: Event, News|Tags: |Comments Off on Scintica and Aspect Imaging Announce New Extended Partnership

Poietis and Assistance Publique – Hôpitaux de Marseille (AP-HM) announce the first installation of a 3D bioprinting platform

Poietis and Assistance Publique - Hôpitaux de Marseille (AP-HM) announce the first installation of a 3D bioprinting platform for manufacturing implantable biological tissues in hospitals The

By |2021-11-25T10:36:47-05:00November 24th, 2021|Categories: News|Comments Off on Poietis and Assistance Publique – Hôpitaux de Marseille (AP-HM) announce the first installation of a 3D bioprinting platform

Scintica and Baker Ruskinn Announce New Extended Partnership

[July 26, 2021] Scintica is excited to announce its new and extended distribution agreement with Baker Ruskinn, global leader and supplier of anaerobic and modified atmosphere solutions for microbiology and tissue/cell culture applications. The Baker Company, global leader in containment technology, owner of Baker Ruskinn, itself a global leader in anaerobic and precision low-oxygen

By |2021-08-04T15:27:52-04:00August 4th, 2021|Categories: Event, News|Tags: |Comments Off on Scintica and Baker Ruskinn Announce New Extended Partnership
Go to Top